{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:00:51Z","timestamp":1793412051403,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hydroxychloroquine (HCQ) is a frontline treatment for autoimmune diseases, including rheumatoid arthritis, Sjogren\u2019s syndrome, and systemic lupus erythematosus (SLE), due to its potent immunomodulatory properties. Efferocytosis, a crucial process for tissue homeostasis by transmitting immune-suppressive signals, is frequently impaired in SLE. We hypothesized HCQ enhances efferocytosis and mediates anti-inflammatory effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A pristane-induced lupus (PIL) mouse model was used to assess the preventive efficacy of HCQ by measuring inflammatory cytokine levels, autoantibody titers, and lupus nephritis severity. Efferocytosis in HCQ-treated macrophages was quantified following co-incubation with apoptotic cells and the expression levels of TAM family receptors post-HCQ stimulation were analyzed <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. The role of MerTK on HCQ-modulated inflammation was revealed by MerTK inhibitor UNC2025.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Long-term HCQ treatment in PIL mice significantly reduced disease activity. HCQ treatment enhanced efferocytosis in RAW264.7 cells, while peritoneal macrophages from HCQ-treated mice showed increased efferocytotic capacity compare to PIL mice. Additionally, HCQ upregulated the expression of the TAM receptor MerTK and Gas6 on macrophages, restoring MerTK levels suppressed by pristane in the spleen of PIL mice. Inhibition of MerTK signaling by UNC2025 mitigated HCQ-mediated enhancements in efferocytosis and reversed the reduction in inflammatory mediators including IL-6 and IFN-\u03b1. HCQ-induced anti-inflammatory markers, such as PPAR\u03b3, LXR, and IL-10, were also alleviated upon MerTK blockade.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides robust <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> evidence that HCQ promotes macrophage efferocytosis and anti-inflammatory reprogramming via MerTK\/Gas6 signaling, offering insights into potential therapeutic mechanisms in SLE management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1524315","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:23:26Z","timestamp":1750051406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Hydroxychloroquine enhances efferocytosis and modulates inflammation via MerTK\/Gas6 signaling in a pristane-induced lupus mouse model"],"prefix":"10.3389","volume":"16","author":[{"given":"Shin-Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ju","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Hung","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Chieh J.","family":"Tsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hen-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Tsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e30330","DOI":"10.7759\/cureus.30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144918","article-title":"Bite of the wolf: innate immune responses propagate autoimmunity in lupus","volume":"131","author":"Gupta","year":"2021","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis\u2014Role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5772\/intechopen.97168","article-title":"Novel therapeutic interventions in systemic lupus erythematosus.,\u201d Lupus - need to know","volume":"6","author":"Athanassiou","year":"2021","journal-title":"IntechOpen"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39741","article-title":"Pin1-targeted therapy for systemic lupus erythematosus","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: new mechanisms for old drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu Rev Med"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1093\/stcltm\/szae044","article-title":"Current cell therapies for systemic lupus erythematosus","volume-title":"Stem Cells Transl Med","author":"Dao","year":"2024"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheumatic Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e12476","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"M\u00fcller-Calleja","year":"2017","journal-title":"Ann Rheumatic Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.7.3327","article-title":"Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents","volume":"75","author":"Ohkuma","year":"1978","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH and the anti-malarial action of chloroquine","volume":"235","author":"Homewood","year":"1972","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031942","article-title":"Toll-like receptor 9\u2013dependent and \u2013independent dendritic cell activation by chromatin\u2013immunoglobulin G complexes","volume":"199","author":"Boul\u00e9","year":"2004","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103509","article-title":"Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells","volume":"24","author":"Kim","year":"2021","journal-title":"iScience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402793","article-title":"Cutting edge: antimalarial drugs inhibit IFN-\u03b2 Production through blockade of cyclic GMP-AMP synthase\u2013DNA interaction","volume":"194","author":"An","year":"2015","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.40559","article-title":"Inhibition of cyclic GMP-AMP synthase using a novel antimalarial drug derivative in trex1-deficient mice","volume":"70","author":"An","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","article-title":"Mechanisms and physiology of the clearance of dead cells by efferocytosis","volume":"21","author":"Boada-Romero","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3253","article-title":"Phagocytosis of apoptotic cells in homeostasis","volume":"16","author":"Arandjelovic","year":"2015","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/imr.12376","article-title":"Apoptotic cell recognition receptors and scavenger receptors","volume":"269","author":"Penberthy","year":"2016","journal-title":"Immunol Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200114122","article-title":"Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences","volume":"108","author":"Fadok","year":"2001","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.52","article-title":"Engulfment signals and the phagocytic machinery for apoptotic cell clearance","volume":"49","author":"Park","year":"2017","journal-title":"Exp Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01708","article-title":"The \u201cPhagocytic synapse\u201d and clearance of apoptotic cells","volume":"8","author":"Barth","year":"2017","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","article-title":"BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis","volume":"43","author":"Edwards","year":"2002","journal-title":"J Lipid Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317701842","article-title":"Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone","volume":"26","author":"Mohammadi","year":"2017","journal-title":"Lupus"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01645","article-title":"The role of efferocytosis in autoimmune diseases","volume":"9","author":"Abdolmaleki","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12826","article-title":"Impaired phagocytosis of apoptotic cell material in serologically active clinically quiescent patients with systemic lupus erythematosis","volume":"19","author":"Huang","year":"2016","journal-title":"Int J Rheumatic Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxy055","article-title":"Efferocytosis and autoimmune disease","volume":"30","author":"Kawano","year":"2018","journal-title":"Int Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00553","article-title":"Phagocytosis of apoptotic cells in resolution of inflammation","volume":"11","author":"Kourtzelis","year":"2020","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.04.006","article-title":"Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity","volume":"60","author":"Yen","year":"2014","journal-title":"Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1401s83","article-title":"The isolation and characterization of murine macrophages","author":"Zhang","year":"2008","journal-title":"Curr Protoc Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.1002284","article-title":"Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation","volume":"186","author":"K\u00f6r\u00f6sk\u00e9nyi","year":"2011","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01409","article-title":"Beyond anti-viral effects of chloroquine\/hydroxychloroquine","volume":"11","author":"Gies","year":"2020","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2018.07.003","article-title":"Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition","volume":"195","author":"Torigoe","year":"2018","journal-title":"Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-06082-5","article-title":"Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line","volume":"261","author":"Ertu\u011frul","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0173712","DOI":"10.1371\/journal.pone.0173712","article-title":"Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS","volume":"12","author":"Qu","year":"2017","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107893","article-title":"Resolving inflammation by TAM receptor activation","volume":"227","author":"Vago","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0909610","article-title":"TNF-\u03b1, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes\/macrophages","volume":"87","author":"Alciato","year":"2010","journal-title":"J Leukocyte Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23539","article-title":"Inhibition of Gas6 promotes crystalline silica-induced inflammatory response of macrophages via blocking autophagy flux","volume":"37","author":"Xie","year":"2022","journal-title":"Environ Toxicol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147525","article-title":"MerTK inhibits the activation of the NLRP3 inflammasome after subarachnoid hemorrhage by inducing autophagy","volume":"1766","author":"Du","year":"2021","journal-title":"Brain Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2016.11.017","article-title":"Pristane induces autophagy in macrophages, promoting a STAT1-IRF1-TLR3 pathway and arthritis","volume":"175","author":"Zhu","year":"2017","journal-title":"Clin Immunol"},{"key":"B47","article-title":"Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production","volume":"32","author":"Li","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103030","article-title":"Autophagy pathways in autoimmune diseases","volume":"136","author":"Keller","year":"2023","journal-title":"J Autoimmun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000484955","article-title":"Chloroquine autophagic inhibition rebalances th17\/treg-mediated immunity and ameliorates systemic lupus erythematosus","volume":"44","author":"An","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170737","article-title":"Hydroxychloroquine inhibits the differentiation of th17 cells in systemic lupus erythematosus","volume":"45","author":"Yang","year":"2018","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/ar4499","article-title":"T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus","volume":"16","author":"Brkic","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242653","article-title":"IL-17: A new actor in IFN-driven systemic autoimmune diseases","volume":"42","author":"Ambrosi","year":"2012","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcp.2016.06.004","article-title":"Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis","volume":"115","author":"Yao","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Alarcon-Segovia","year":"1995","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1524315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:23:29Z","timestamp":1750051409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1524315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2025.1524315"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1524315","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1524315"}}